Skip to content
PubMed This is a summary of 13 peer-reviewed journal articles Updated
Obstetrics

Survivorship: Pregnancy Risks and Long-Term Monitoring

At a Glance

Pregnancies after Asherman syndrome are moderate-to-high risk due to potential complications like placenta accreta and restricted fetal growth. Working with a Maternal-Fetal Medicine (MFM) specialist is crucial for advanced ultrasound monitoring and safe delivery planning.

Achieving a pregnancy after Asherman syndrome is a significant milestone, but it also marks the beginning of a new phase of specialized care. Because the uterine lining has been scarred, the way the placenta attaches and the way the uterus supports a growing baby are different than in a typical pregnancy [1][2].

Understanding Pregnancy Risks

Most pregnancies after Asherman syndrome are successful, but they are classified as moderate-to-high risk [3]. This is because the scar tissue can disrupt the healthy development of the decidua (the specialized lining that forms during pregnancy) [2].

Placental Complications

The most significant risk is Placenta Accreta Spectrum (PAS) [2]. This occurs when the placenta attaches too deeply into the uterine wall because the protective lining is thin or missing [1][2].

  • PAS can be difficult to see on standard ultrasounds and may not be discovered until delivery [4].
  • It increases the risk of postpartum hemorrhage (heavy bleeding after birth), as the placenta may not separate easily from the uterine wall [2][5].

Fetal Growth and Timing

  • Intrauterine Growth Restriction (IUGR): Because the scarred lining may not provide the same level of blood flow as a healthy lining, the baby may grow more slowly than expected [2][5].
  • Preterm Birth: There is an increased chance of the baby arriving before 37 weeks, often due to placental issues or the need for an early delivery to manage maternal health [2][6].

The Role of the MFM Specialist

Due to these risks, it is crucial to include a Maternal-Fetal Medicine (MFM) specialist—an obstetrician with advanced training in high-risk pregnancies—in your care team [3][5].

  • Advanced Imaging: MFMs use high-resolution ultrasounds to monitor placental placement and fetal growth more closely than a standard OBGYN [3].
  • Delivery Planning: They help coordinate a safe delivery plan, ensuring that the hospital is prepared for potential complications like heavy bleeding [7][5].

Alternative Paths to Family Building

For some patients, despite expert surgical intervention, the uterine lining (the functionalis layer) remains too thin or damaged to support a pregnancy safely. If your doctor determines that the uterus cannot be restored, it is important to know that gestational surrogacy remains a viable alternative. In surrogacy, a healthy embryo created from your (or a donor’s) egg and sperm is transferred to the uterus of a gestational carrier. While emotionally and financially taxing, this is a proven path to biological parenthood for patients with severe, treatment-resistant Asherman syndrome.

Long-Term Monitoring and Recurrence

If you have completed your family or are not currently trying to conceive, you may wonder if the scar tissue will return.

  • Spontaneous Recurrence: Asherman syndrome does not usually “start” on its own; it requires a trigger like trauma or infection [8]. However, if your surgery was recent, there is a risk of adhesion reformation (the scars growing back) during the healing phase [9][10].
  • Symptom Tracking: Even if you are not seeking pregnancy, you should monitor for menstrual disturbances or cyclical pelvic pain. These can indicate that adhesions are blocking the flow of a period, which can lead to discomfort or other uterine issues [11][12].

While the journey through Asherman syndrome requires persistence and extra care, understanding these long-term factors allows you to advocate for the specialized monitoring you need for a healthy future [3][13].

Common questions in this guide

What are the pregnancy risks after having Asherman syndrome?
Pregnancies after Asherman syndrome carry an increased risk of complications like placenta accreta, restricted fetal growth, and preterm birth. This is because uterine scar tissue can disrupt the healthy development of the protective lining needed during pregnancy.
Why do I need a Maternal-Fetal Medicine (MFM) specialist for my pregnancy?
An MFM specialist has advanced training in high-risk pregnancies. They use high-resolution ultrasounds to monitor placental placement and fetal growth, and they help coordinate a safe delivery plan to manage potential complications like heavy bleeding.
Can Asherman syndrome scar tissue grow back?
Yes, there is a risk of adhesions reforming during the healing phase shortly after surgery. While Asherman syndrome doesn't start on its own without a trigger, you should monitor for cyclical pelvic pain or changes in your period, which can indicate the scars have returned.
What are my options if my uterus cannot carry a pregnancy?
If surgical interventions cannot repair the uterine lining sufficiently, gestational surrogacy is a viable path to biological parenthood. An embryo is transferred to a healthy gestational carrier to ensure a safe pregnancy.
How does my doctor check for placenta accreta during pregnancy?
Your Maternal-Fetal Medicine specialist will use high-resolution ultrasounds, sometimes called a placental sweep, during your second trimester. This specialized imaging closely monitors placental placement to identify abnormalities early, allowing for a safer delivery plan.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Since I have a history of Asherman syndrome, can you refer me to a Maternal-Fetal Medicine (MFM) specialist for an early placental assessment?
  2. 2.How frequently should we monitor my baby's growth to check for signs of intrauterine growth restriction (IUGR)?
  3. 3.What is your plan for managing potential postpartum hemorrhage during my delivery?
  4. 4.How often should I have follow-up ultrasounds or hysteroscopies if I am not planning to get pregnant immediately?
  5. 5.Do you recommend a specialized ultrasound (like a 'placental sweep') in the second trimester to look for placenta accreta?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (13)
  1. 1

    Secondary Prevention of Intrauterine Adhesions Following Hysteroscopic Surgery in Women With Asherman Syndrome: Is Something Better Than Nothing?

    Kelley AS, Giuliani E, Schon SB

    Clinical obstetrics and gynecology 2020; (63(2)):320-326 doi:10.1097/GRF.0000000000000510.

    PMID: 31815774
  2. 2

    Effects of Asherman Syndrome on Maternal and Neonatal Morbidity with Evaluation by Conception Method.

    Wang J, Movilla P, Morales B, et al.

    Journal of minimally invasive gynecology 2021; (28(7)):1357-1366.e2 doi:10.1016/j.jmig.2020.10.004.

    PMID: 33065259
  3. 3

    "The threat of Asherman syndrome": a propensity score-matched study of fetal-maternal outcomes.

    Hanstede MMF, Veersema S, Emanuel MH, et al.

    Fertility and sterility 2025; (124(5 Pt 2)):1104-1114 doi:10.1016/j.fertnstert.2025.06.027.

    PMID: 40578664
  4. 4

    Incidence, risk factors and maternal outcomes of unsuspected placenta accreta spectrum disorders: a retrospective cohort study.

    Zhao J, Li Q, Liao E, et al.

    BMC pregnancy and childbirth 2024; (24(1)):76 doi:10.1186/s12884-024-06254-z.

    PMID: 38262978
  5. 5

    The perinatal outcomes of women treated for Asherman syndrome: a propensity score-matched cohort study.

    Mára M, Borčinová M, Lisá Z, et al.

    Human reproduction (Oxford, England) 2023; (38(7)):1297-1304 doi:10.1093/humrep/dead092.

    PMID: 37196339
  6. 6

    The birth weight in pregnant women with Asherman syndrome compared to normal intrauterine cavity: A case-control study.

    Baradwan S, Baradwan A, Bashir M, Al-Jaroudi D

    Medicine 2018; (97(32)):e11797 doi:10.1097/MD.0000000000011797.

    PMID: 30095642
  7. 7

    Incidence and Clinical Implications of Placenta Accreta Spectrum after Treatment for Asherman Syndrome.

    Tavcar J, Movilla P, Carusi DA, et al.

    Journal of minimally invasive gynecology 2023; (30(3)):192-198 doi:10.1016/j.jmig.2022.11.013.

    PMID: 36442752
  8. 8

    Prevalence and risk factors of intrauterine adhesions in women with a septate uterus: a retrospective cohort study.

    Shen M, Duan H, Chang Y, Lin Q

    Reproductive biomedicine online 2022; (44(5)):881-887 doi:10.1016/j.rbmo.2022.02.004.

    PMID: 35361544
  9. 9

    The predictive value of serum IL-17A and IL-6 expression in postoperative recurrence in patients with intrauterine adhesion.

    Cui X, Xiao HC, Pan W

    American journal of reproductive immunology (New York, N.Y. : 1989) 2024; (91(1)):e13808 doi:10.1111/aji.13808.

    PMID: 38282600
  10. 10

    Extended intrauterine balloon stent use to prevent adhesion reformation after hysteroscopic adhesiolysis: a randomized trial.

    Luo Y, Liu Y, Xiao Y, et al.

    Fertility and sterility 2025; (124(1)):144-152 doi:10.1016/j.fertnstert.2025.01.024.

    PMID: 39884334
  11. 11

    CSF1-associated decrease in endometrial macrophages may contribute to Asherman's syndrome.

    Liu D, Wang J, Zhao G, et al.

    American journal of reproductive immunology (New York, N.Y. : 1989) 2020; (83(1)):e13191 doi:10.1111/aji.13191.

    PMID: 31536655
  12. 12

    Reproductive Outcome of Patients with Asherman's Syndrome: A SAIMS Experience.

    Bhandari S, Bhave P, Ganguly I, et al.

    Journal of reproduction & infertility 2015; (16(4)):229-35.

    PMID: 27110522
  13. 13

    A retrospective cohort study to examine factors affecting live birth after hysteroscopic treatment of intrauterine adhesions.

    Zhao Y, Huang X, Huang R, et al.

    Fertility and sterility 2024; (121(5)):873-880 doi:10.1016/j.fertnstert.2024.01.022.

    PMID: 38246404

This page is for informational purposes only and does not replace professional medical advice. Always consult your obstetrician or Maternal-Fetal Medicine specialist regarding your specific pregnancy risks and care plan.

Get notified when new evidence is published on Asherman syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.